SynCardia Systems, Inc. Selected as a Finalist for the 2012 MEDTEC Europe Innovation Awards

(Click here for details)
SynCardia Product Manager Karen Stamm holds the SynCardia temporary Total Artificial Heart while wearing the Freedom(R) portable driver, the world’s first wearable power supply for the Total Artificial Heart.

TUCSON, AZ--(Marketwire - January 26, 2012) -

SynCardia Systems, Inc. (www.syncardia.com), manufacturer of the world’s first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that it has been nominated for one of the most prestigious awards in the European medical device industry.

The Freedom® portable driver, the world’s first wearable power supply for the SynCardia temporary Total Artificial Heart, has been shortlisted for “Most Innovative Cardiac Product of the Year” as part of the MEDTEC European Medical Device Technology (EMDT) Innovation Awards. The Awards are the only European awards dedicated to recognizing achievements in the medical device sector.

“These awards are regarded as a universal benchmark of quality within the medical-device industry,” said Michael Garippa, SynCardia CEO/President. “Being shortlisted is a tremendous achievement. The Freedom portable driver has been pivotal in the Total Artificial Heart becoming the new standard of care for end-stage biventricular heart failure.”

Weighing approximately 6 kg (13.5 lbs), the Freedom portable driver allows stable Total Artificial Heart patients to be discharged from the hospital to enjoy life at home while they wait for a matching donor heart. The Freedom driver is CE approved for use in Europe and undergoing an FDA-approved Investigational Device Exemption (IDE) clinical study in the U.S. More than 70 patients worldwide have been supported by the Freedom driver, accounting for more than 24 years of patient support.

This year’s winners will be announced on March 14, 2012, at a special ceremony during MEDTEC Europe 2012, in the Atrium of the Messe Stuttgart in Stuttgart, Germany.

About the SynCardia temporary Total Artificial Heart
SynCardia Systems, Inc. (Tucson, AZ) is the privately-held manufacturer of the world’s first and only FDA, Health Canada and CE approved Total Artificial Heart. Originally used as a permanent replacement heart... read more

www.syncardia.com
Like SynCardia on Facebook
Follow SynCardia on Twitter - @SynCardia
Connect with SynCardia on LinkedIn